01 June 2005 : Hypothesis
The implantation of a permanent transvenous endocardial pacemaker in 42 dogs: a retrospective study
Oriol Domenech, Roberto Santilli, Danitza Pradelli, Claudio BussadoriMed Sci Monit 2005; 11(6): BR168-175 :: ID: 16485
Abstract
Summary
Background: The primary indication for pacemaker therapy in dogs and cats is symptomatic bradyarrhythmia that does not respond to medical treatment. Different techniques have been used for pacemaker implantation since 1968. Transvenous endocardial pacemaker implantation is a minimally invasive method and represents the fi rst choice of treatment for this type of arrhythmia.
Material/Methods: The authors reviewed retrospectively the indications, effi cacy, complications, and long-term outcome
in 42 cases of transvenous endocardial pacemaker implantation in dogs.
Results: Complications which required a second intervention occurred in 10 dogs (23.8%), while complications
that did not require another procedure occurred in 5 dogs (11.9%). Two of the 42 patients died due to the pacemaker implantation (mortality: 4.76%). The mean survival age of those patients
with a pacemaker that survived the procedure was 11.4 years.
Conclusions: The life expectancy of our patients carrying a pacemaker was higher than the general life expectancy published in a study on a large population of dogs. The low mortality rate and long life expectancy of dogs treated makes transvenous pacemaker implantation an effi cacious and safe alternative for treatment of those bradyarrhythmias that do not respond to medical therapy
Keywords: Bradycardia - therapy, Dermatitis, Atopic - complications, Bradycardia - therapy, Dermatitis, Atopic - complications, Dogs, Equipment Design, Pacemaker, Artificial - adverse effects, Physical Conditioning, Animal, Radiography, Thoracic, Seizures - etiology, Syncope - etiology, Time Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952